Critical issue is rapidity of review of new drugs.
Rodger
Alan
A
D000970:Antineoplastic Agents / Q000191:economics* / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000191:economics*; D011306:Prescription Fees; D013222:State Medicine
D000970:Antineoplastic Agents